GALANTOS PHARMA GMBH has a total of 11 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are YANG GENGLIANG, HYPNION INC and EFFECTOR THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Maelicke Alfred | 9 |
#2 | Alfred Maelicke | 1 |
#3 | Maelicke Alfred Prof Dr | 1 |
#4 | Weichel Carolin | 1 |
Publication | Filing date | Title |
---|---|---|
US2009253654A1 | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment | |
US2007213318A1 | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment | |
EP1777222A1 | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |